Han Y, Huang Y
Front Public Health. 2025; 12:1444249.
PMID: 39935745
PMC: 11811093.
DOI: 10.3389/fpubh.2024.1444249.
Iwashyna T, Hauschildt K, Ni V, Lynch J, Tomori C
Ann Am Thorac Soc. 2024; 22(3):322-324.
PMID: 39700509
PMC: 11892665.
DOI: 10.1513/AnnalsATS.202411-1213ED.
Khalil N, Ahmed E, Tharwat T, Mahmoud Z
RSC Adv. 2024; 14(42):30647-30661.
PMID: 39324041
PMC: 11423417.
DOI: 10.1039/d4ra04686b.
Xing X, Xu C, Al Amer F, Shi L, Zhu J, Lin L
Contemp Clin Trials. 2024; 145:107646.
PMID: 39084407
PMC: 11392622.
DOI: 10.1016/j.cct.2024.107646.
Cwajna M, Hamouda A, Kendall N, Ghozy S, Elder B, Kallmes D
Transl Stroke Res. 2024; .
PMID: 38831158
DOI: 10.1007/s12975-024-01260-x.
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses.
Scheim D, Parry P, Rabbolini D, Aldous C, Yagisawa M, Clancy R
Viruses. 2024; 16(4).
PMID: 38675987
PMC: 11054389.
DOI: 10.3390/v16040647.
Disclosing and Managing Non-Financial Conflicts of Interest in Scientific Publications.
Resnik D
Res Ethics. 2023; 19(2):121-138.
PMID: 37621567
PMC: 10448996.
DOI: 10.1177/17470161221148387.
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults.
Fraiman J, Erviti J, Jones M, Greenland S, Whelan P, Kaplan R
Vaccine. 2022; 40(40):5798-5805.
PMID: 36055877
PMC: 9428332.
DOI: 10.1016/j.vaccine.2022.08.036.
Assessing short-term risk of ischemic stroke in relation to all prescribed medications.
Janszky I, Vardaxis I, Lindqvist B, Horn J, Brumpton B, Strand L
Sci Rep. 2021; 11(1):21673.
PMID: 34737336
PMC: 8568938.
DOI: 10.1038/s41598-021-01115-7.
Mapping conflict of interests: scoping review.
Chimonas S, Mamoor M, Zimbalist S, Barrow B, Bach P, Korenstein D
BMJ. 2021; 375:e066576.
PMID: 34732464
PMC: 8565086.
DOI: 10.1136/bmj-2021-066576.
Tackling Current Biomedical Challenges With Frontier Biofabrication and Organ-On-A-Chip Technologies.
Celikkin N, Presutti D, Maiullari F, Fornetti E, Agarwal T, Paradiso A
Front Bioeng Biotechnol. 2021; 9:732130.
PMID: 34604190
PMC: 8481890.
DOI: 10.3389/fbioe.2021.732130.
The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions.
Shams S, Martinez J, Dawson J, Flores J, Gabriel M, Garcia G
Front Pharmacol. 2021; 12:680043.
PMID: 34122106
PMC: 8194305.
DOI: 10.3389/fphar.2021.680043.
A comparative analysis of important public clinical trial registries, and a proposal for an interim ideal one.
Venugopal N, Saberwal G
PLoS One. 2021; 16(5):e0251191.
PMID: 33974649
PMC: 8112656.
DOI: 10.1371/journal.pone.0251191.
Fenamates as Potential Therapeutics for Neurodegenerative Disorders.
Hill J, Zawia N
Cells. 2021; 10(3).
PMID: 33809987
PMC: 8004804.
DOI: 10.3390/cells10030702.
Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997-2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR).
Bennett C, Hoque S, Olivieri N, Taylor M, Aboulafia D, Lubaczewski C
EClinicalMedicine. 2021; 31:100693.
PMID: 33554084
PMC: 7846671.
DOI: 10.1016/j.eclinm.2020.100693.
The plague of unexpected drug recalls and the pandemic of falsified medications in cardiovascular medicine as a threat to patient safety and global public health: A brief review.
Swieczkowski D, Zdanowski S, Merks P, Szarpak L, Vaillancourt R, Jaguszewski M
Cardiol J. 2020; 29(1):133-139.
PMID: 33346374
PMC: 8890415.
DOI: 10.5603/CJ.a2020.0168.
Clinical Trials Registry - India: A decadal perspective.
Rao M, Maulik M, Juneja A, Adhikari T, Sharma S, Gupta J
Indian J Pharmacol. 2020; 52(4):272-282.
PMID: 33078728
PMC: 7722906.
DOI: 10.4103/ijp.IJP_24_20.
The FDA-approved drugs ticlopidine, sertaconazole, and dexlansoprazole can cause morphological changes in C. elegans.
Galford K, Jose A
Chemosphere. 2020; 261:127756.
PMID: 32731027
PMC: 7606649.
DOI: 10.1016/j.chemosphere.2020.127756.
Stakeholders' knowledge, attitudes and practices to pharmacovigilance and adverse drug reaction reporting in clinical trials: a mixed methods study.
Riordan D, Kinane M, Walsh K, Shiely F, Eustace J, Bermingham M
Eur J Clin Pharmacol. 2020; 76(10):1363-1372.
PMID: 32507924
DOI: 10.1007/s00228-020-02921-0.
A hierarchical testing approach for detecting safety signals in clinical trials.
Tan X, Chen B, Sun J, Patel T, Ibrahim J
Stat Med. 2020; 39(10):1541-1557.
PMID: 32050050
PMC: 8258607.
DOI: 10.1002/sim.8495.
